Hikma Pharmaceuticals PLC (LON:HIK)
1,636.00
+12.00 (0.74%)
Aug 21, 2026, 4:35 PM GMT
Hikma Pharmaceuticals Employees
Hikma Pharmaceuticals had 9,500 employees as of June 30, 2026. The number of employees increased by 100 or 1.06% since the number was reported on December 31, 2025.
Employees
9,500
Change
100
Growth
1.06%
Revenue / Employee
271.25K GBP
Profits / Employee
30.70K GBP
Market Cap
3.44B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 9,500 | 100 | 1.06% |
| Dec 31, 2025 | 9,400 | -100 | -1.05% |
| Dec 31, 2024 | 9,500 | 400 | 4.40% |
| Dec 31, 2023 | 9,100 | 300 | 3.41% |
| Dec 31, 2022 | 8,800 | 100 | 1.15% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Haleon | 24,535 |
| HUTCHMED (China) | 1,790 |
| Allergy Therapeutics | 584 |
| ECO Animal Health Group | 213 |
| Shield Therapeutics | 61 |
| Venture Life Group | 43 |
| Chill Brands Group | 11 |
| Provexis | 2 |
Hikma Pharmaceuticals News
- 5 days ago - Hikma Pharmaceuticals price target raised to 1,870 GBp from 1,700 GBp at Citi - TheFly
- 16 days ago - Hikma Pharmaceuticals H1 Earnings Call Highlights - MarketBeat
- 16 days ago - Hikma Delivers Solid H1 2026 Performance, Reiterates Full-Year Outlook; Stock Up - Nasdaq
- 16 days ago - Hikma Pharmaceuticals Earnings Call Transcript: H1 2026 - Transcripts
- 16 days ago - Hikma Pharmaceuticals Quarterly report: H1 2026 - Filings
- 16 days ago - Hikma Pharmaceuticals Slides: H1 2026 - Filings
- 16 days ago - UK's Hikma Pharma holds annual outlook, preps for US generic drug tariffs - Reuters
- 4 weeks ago - Shares in Generic-Drug Makers Fall After Trump's Tariff Plan - WSJ